Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher L Amling

Showing results (1-10 of 199) with videos related to

Pageof 20
Sort By:
Urologic Oncology|December 22, 2004
The association between obesity and the progression of prostate and renal cell carcinomaChristopher L Amling
Current Opinion in Urology|April 9, 2005
Relationship between obesity and prostate cancerChristopher L Amling
Current Treatment Options in Oncology|August 15, 2006
Prostate-specific antigen and detection of prostate cancer: What have we learned and what should we recommend for screening?Christopher L Amling
The Urologic Clinics of North America|April 25, 2006
Biochemical recurrence after localized treatmentChristopher L Amling
Current Opinion in Urology|April 3, 2008
Current decision-making in prostate cancer therapyJared Cox, Christopher L Amling
Urologic Oncology|March 28, 2008
High cholesterol levels are associated with reduced prostate cancer mortality rates during periods of high but not low statin use in the United StatesJanet L Colli, Christopher L Amling
Current Urology Reports|April 29, 2010
Prostate cancer screening: what we have learned from the PLCO and ERSPC trialsJeffrey La Rochelle, Christopher L Amling
Urologic Oncology|March 28, 2008
Exploring causes for declining prostate cancer mortality rates in the United StatesJanet L Colli, Christopher L Amling
Journal of the National Comprehensive Cancer Network : JNCCN|February 10, 2010
Appropriate use of nomograms to guide prostate cancer treatment selectionAndrew K Lee, Christopher L Amling
Current Urology Reports|April 18, 2009
Chemoprevention of prostate cancer: what can be recommended to patients?Janet L Colli, Christopher L Amling
Pageof 20

Showing results (1-10 of 199) with videos related to

Sort By:
Pageof 20
Urologic Oncology|December 22, 2004
The association between obesity and the progression of prostate and renal cell carcinomaChristopher L Amling
Current Opinion in Urology|April 9, 2005
Relationship between obesity and prostate cancerChristopher L Amling
Current Treatment Options in Oncology|August 15, 2006
Prostate-specific antigen and detection of prostate cancer: What have we learned and what should we recommend for screening?Christopher L Amling
The Urologic Clinics of North America|April 25, 2006
Biochemical recurrence after localized treatmentChristopher L Amling
Current Opinion in Urology|April 3, 2008
Current decision-making in prostate cancer therapyJared Cox, Christopher L Amling
Urologic Oncology|March 28, 2008
High cholesterol levels are associated with reduced prostate cancer mortality rates during periods of high but not low statin use in the United StatesJanet L Colli, Christopher L Amling
Current Urology Reports|April 29, 2010
Prostate cancer screening: what we have learned from the PLCO and ERSPC trialsJeffrey La Rochelle, Christopher L Amling
Urologic Oncology|March 28, 2008
Exploring causes for declining prostate cancer mortality rates in the United StatesJanet L Colli, Christopher L Amling
Journal of the National Comprehensive Cancer Network : JNCCN|February 10, 2010
Appropriate use of nomograms to guide prostate cancer treatment selectionAndrew K Lee, Christopher L Amling
Current Urology Reports|April 18, 2009
Chemoprevention of prostate cancer: what can be recommended to patients?Janet L Colli, Christopher L Amling
Pageof 20